Human Cloning Prohibition Act Of 2003
Mr. Chairman, I thank the gentlewoman from California for the leadership that she has shown on this issue as well. Mr. Chairman, let us be clear again yet today. This is not a fight about banning human cloning. We all agree cloning for…
Mr. Chairman, I thank the gentlewoman from California for the leadership that she has shown on this issue as well.
Mr. Chairman, let us be clear again yet today. This is not a fight about banning human cloning. We all agree cloning for purposes of creating another human being is wrong and it should be prohibited.
Instead, what we are arguing about is allowing scientific research to continue that can lead to cures for Alzheimer's, Parkinson's, diabetes, spinal cord injuries. Unfortunately, H.R. 534's approach would take a Howitzer after a house fly.
What about bone marrow transplants? What about in vitro fertilization? If we logically extend the argument for H.R. 534, that is next.
Some of the most advanced and exciting stem cell research in the world is occurring at the University of Wisconsin. I have had the opportunity over a few occasions to visit their research department; and while the research they are doing there itself is exciting, what is most impressive is how much in tandem the researchers of the science and the ethics department work.
What most people do not realize on this subject is that therapeutic stem cell research is already a heavily regulated industry. The FDA has strict requirements on what they can and cannot do.
But my main point is this: we need to do this if for no other reason than to provide leadership for the rest of the world. I am more comfortable knowing that our country, our researchers, our FDA is providing oversight and guidance on this discovery which could lead almost anywhere. Lets make sure that with our leadership, the discoveries will be used for the betterment of human kind rather than for nefarious purposes.
Mr. Chairman, I urge passage of the substitute and rejection of H.R. 534.
Mr. Chairman, I rise today in strong opposition to H.R. 534 and in strong support for the Greenwood/Deutsch/DeGette/Eshoo/Kirk substitute. The United States has long been the leader in medical research and biotechnology. Biotechnological advances have the potential to transform the way we treat many debilitating diseases.
One promising way that biotechnology is changing our lives is through the potential of stem cell research and therapeutic cloning. Therapeutic cloning is not cloning in the sense most people use the term, namely using technology to create a person who is a genetically identical copy of someone else. That type of cloning is reproductive cloning and is rightfully subject to a ban. The Greenwood Substitute would do just that.
In addition, the Greenwood Substitute would also permit therapeutic cloning. The potential therapies that may be developed from therapeutic cloning are significant. Therapeutic cloning will help researchers pursue stem cell therapies that could impact the lives of millions of Americans suffering from many of our most devastating illnesses, including Alzheimer's disease, Parkinson's disease, ALS, heart disease, cancer, and spinal cord injury. Further, this technology offers hope to the more than 1 million American children who suffer from juvenile diabetes because of the potential to turn these cells into insulin- producing cells.
We have entered the 21st Century and are on the verge of breakthrough biomedical discoveries that could save millions of lives. H.R. 534 would halt vital research that has the potential to revolutionize the biotech industry. Stopping this research in its tracks puts the United States at a clear and immediate disadvantage. Other nations such as Britain, France, Sweden, and the Netherlands, all of which currently have laws allowing therapeutic cloning from designated sources, continue to advance the technology. Molecular and cellular biologists committed to this research have already begun to look abroad, and they take with them lucrative investments from the biotech industry. Other scientists have dropped the cause all together, wasting precious time in the development of life-saving procedures that will someday help millions of people.
Back home in Wisconsin, I have had the privilege of meeting with Dr. James Thomson, a developmental biologist at the University of Wisconsin-Madison, who has contributed greatly to stem cell research. Three years ago he became the first person to isolate stem cells from human embryos. He has not taken on this work lightly, he has thought carefully about the ethical implications of his research. For Dr. Thompson, the moral questions about embryo experimentation were not difficult to resolve; he concluded that research was the ``better ethical choice.''
Because embryonic stem cells have the potential to grow into any cell or tissue in the human body, scientists say they hold great potential for repairing damaged tissues or organs. But to extract them requires that the embryo be destroyed, therefore, every year since 1995, Congress has attached language to its appropriations legislation to ban taxpayer financing of the work.
This ban requires that Dr. Thomson work into different laboratories, one of them in secret. He works primarily out of the university's primate center. This is his federally financed laboratory where he studies stem cells derived from the embryos of rhesus monkeys and marmosets.
When he conducts research on human cells, he must, however, move to an entirely different laboratory. This one is paid for by WiCell Research Institute, a corporation set up as a subsidiary of the Wisconsin Alumni Research Foundation, the nonprofit group that holds the patent to Dr. Thomson's work. The location of this lab has never been disclosed to ensure the safety of the workers.
Freedom of research has led to the development of over 117 biotech products that have helped more than 250 million people worldwide. In addition, the biotech industry generated $28.5 billion in revenues in 2001, an increase of more than 350 percent in just ten years. Further, employment within the sector more than doubled in the same time period.
The United States has an obligation to demonstrate our continued leadership in this arena and we can only do so with the support of our government. We cannot afford the loss of resources that a chilled scientific climate will bring. We should not cede our leadership, or our industry, to other nations.
I urge my colleagues to vote no on the Weldon bill. Support responsible research, vote yes on the Greenwood Substitute.